GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
CEPS(Rs) | 38.94 | 39.75 | 26.50 | 21.60 | 10.38 |
What is the latest Cash Earnings per Share (CEPS) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Cash Earnings per Share (CEPS) |
---|---|
Mar2024 | 38.94 |
Mar2023 | 39.75 |
Mar2022 | 26.50 |
Mar2021 | 21.60 |
Mar2020 | 10.38 |
How is Cash Earnings per Share (CEPS) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Cash Earnings per Share (CEPS) | % Change | |
---|---|---|---|
Mar2024 | 38.94 | -2.04 | |
Mar2023 | 39.75 | 50.00 | |
Mar2022 | 26.5 | 22.69 | |
Mar2021 | 21.6 | 108.09 | |
Mar2020 | 10.38 | - |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹37,342.5 Cr | 11.1% | 0.7% | -6.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 11.1% |
0.7% |
-6.7% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses